- Home
- Products
- Clinical Trials
- About QI
- Mission Statement
- News
- Publications
- Contact QI
- Resources
- Locating Clinical Trials
- National Cancer Institute
- University of South Alabama
- NCBI
- National Alliance of Breast Cancer
- National Breast Cancer Organization
- National Breast Cancer Coalition
- Young Survival Coalition
- The Mayo Clinic
- Cancer Center of John Hopkins
- Sloan Kettering Cancer Center
- Harvard Cancer Center
 |
Products
The current research and clinical trials support three product lines the company is pursuing:
Individualized Cancer Immunotherapy
System
This is our primary target product at this time. A complete description
can be found in the
Product Background portion of the web
site. The vaccine is individually prepared for patients already
diagnosed with breast cancer. Blood drawn from a patient is treated with
our patented process, and then cells are injected back into the patient
in three doses, stimulating the patient's own immune response.
Cancer Monitoring Test
This test uses some of the same patented technology as the
Individualized Cancer Immunotherapy to monitor blood levels of the
immune response in a patient following treatment. It can be used to
monitor the remission process or done on a regular basis to ensure the
vaccine stays effective. This is a simple blood draw, minimally invasive
to the patient and very economical.
Cancer Screening Test
This test is an extension of the monitoring test and will require
further clinical trials and documentation. However, the company is
pursuing this product as a simple, affordable blood test, very much like
the widely used PSA test. Further studies are needed to prove its
reliability in breast cancer and possibly other types of cancer as well.